All Type of News
Zydenar to complete its new drug registration
The KFDA has approved a new drug purely developed by a Korean pharmaceutical company called Zydena, an impotence drug, which will be the 10th new drug in Korea following "Factive" of LG Life Science. The KFDA announce...
Kolon to open 3 W-stores in Seoul.
Kolon Wellcare (www.wstore.co.kr) opened 3 W-stores on Nov. 11 as the 17th in Sinchon store, the 18th on Nov. 17 in Ilsan Whajeong store and the 19th on Nov. 28 in Songpa Geoyeo store.
Sinchon W-store establishe...
No longer upper limits of NHI coverage days from next year.
The NHI (National Health Insurance) coverage duration has been restricted to no more than 365 days a year, and the extra charges beyond that period should be born by the patient's own payment under the system called "...
HurimBiocel succeeded in animal study on cerebral infarction
Hurim Biocel announced in "49th Fall Scientific Conference" of the Korea Society of Infertility at Yonsei Univ. College of Medicine on Nov. 25 that the company had succeeded in the animal study on the cerebral infarct...
Lipidil Supra, promising preventive effects for coronary heart disease
Green Cross said that a new anti-cholesterol drug, Lipidil Supra (fenofibrate) showed a promising effect for the diabetic patients to prevent coronary heart diseases and to reduce significantly a risk of non-fatal myo...
Daewoong to commit with CoQ10 product markets.Daewoong has launched a Coenzyme product business with Gemron plus CoQ10 for the promotion of fatigue recovery and prevention of the aging and chronic diseases, claiming that Ge...
|
Bukwang's Exima tab. to prove COPD improvement
Bukwang reported that the improvement of COPD symptoms was found in addition to bronchodilatation effects when administering Exima, a new methylxanthine drug.
In the Korea Society of TB and Respiratory Tract System...
GSK to get transfer of two company related domains.
GSK Korea has received a transfer of two company related website domains on free of charge such as "Glaxosb.com" and "Glaxo-sb.com" from Prof. Kang Jin-woo of Youngnam Univ. College of Science and Engineering and the ...
Dongsung to transform for a global prescription drug company.
Dongsung (CEO: Lee Yang-goo) announced on Nov. 25 during the 48th anniversary ceremony that the company should be born again as a global marketing and prescription centered company to meet with a global era, and to ac...
NHI coverage to extend Tamiflu from Dec. 1.
A massive NHI coverage will be extended to Tamiflu for the treatment of AI, taking effect from Dec. 1 this year.
The NHI reimbursement will be made for Tamiflu when medicating for the prevention and treatment of AI...
